Spiro Rombotis
2014
In 2014, Spiro Rombotis earned a total compensation of $558.4K as President and Chief Executive Officer at Cyclacel Pharmaceuticals, a 51% decrease compared to previous year.
Compensation breakdown
| Salary | $530,553 |
|---|---|
| Other | $27,808 |
| Total | $558,361 |
Rombotis received $530.6K in salary, accounting for 95% of the total pay in 2014.
Rombotis also received $27.8K in other compensation.
Rankings
In 2014, Spiro Rombotis' compensation ranked 9,918th out of 13,032 executives tracked by ExecPay. In other words, Rombotis earned more than 23.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,918 out of 13,032 | 24th |
Division Manufacturing | 3,761 out of 4,966 | 24th |
Major group Chemicals And Allied Products | 1,294 out of 1,686 | 23rd |
Industry group Drugs | 1,033 out of 1,365 | 24th |
Industry Pharmaceutical Preparations | 792 out of 1,043 | 24th |
Source: SEC filing on April 11, 2016.
Rombotis' colleagues
We found two more compensation records of executives who worked with Spiro Rombotis at Cyclacel Pharmaceuticals in 2014.
News
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2023 pay slips 13% to $661K
May 7, 2024
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2022 pay falls 43% to $764K
April 28, 2023
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2021 pay slips 5% to $1.3M
April 26, 2022
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2020 pay jumps 39% to $1.4M
April 29, 2021
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2019 pay jumps 35% to $1M
May 12, 2020